chr6-152325290-C-T
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The ENST00000367255.10(SYNE1):c.15451G>A(p.Val5151Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000502 in 1,614,166 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V5151V) has been classified as Likely benign.
Frequency
Consequence
ENST00000367255.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNE1 | NM_182961.4 | c.15451G>A | p.Val5151Met | missense_variant | 81/146 | ENST00000367255.10 | NP_892006.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNE1 | ENST00000367255.10 | c.15451G>A | p.Val5151Met | missense_variant | 81/146 | 1 | NM_182961.4 | ENSP00000356224 | P1 | |
SYNE1 | ENST00000423061.6 | c.15238G>A | p.Val5080Met | missense_variant | 80/146 | 1 | ENSP00000396024 | |||
SYNE1 | ENST00000490135.6 | n.2797G>A | non_coding_transcript_exon_variant | 5/11 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152168Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000998 AC: 251AN: 251404Hom.: 5 AF XY: 0.00138 AC XY: 188AN XY: 135888
GnomAD4 exome AF: 0.000534 AC: 781AN: 1461882Hom.: 11 Cov.: 32 AF XY: 0.000770 AC XY: 560AN XY: 727244
GnomAD4 genome AF: 0.000190 AC: 29AN: 152284Hom.: 1 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74472
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 10, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 20, 2018 | - - |
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | SYNE1: BP4, BS2 - |
SYNE1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at